SHLTN — SHL Telemedicine Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣39.65m
- CH₣32.55m
- $58.69m
Annual cashflow statement for SHL Telemedicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.9 | 0.215 | -6.86 | -27.8 | -15.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 14.9 | -3.68 | -1.09 | 17.6 | 7.97 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.45 | -3.74 | -1.24 | 2.25 | -1.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.185 | -0.073 | -1.5 | -0.372 | -1.82 |
| Capital Expenditures | -3.26 | -6.9 | -5.49 | -3.66 | -3.06 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -37.7 | 0.471 | -3.85 | 9.7 | 10.6 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -41 | -6.43 | -9.35 | 6.03 | 7.57 |
| Financing Cash Flow Items | — | -0.13 | -1.91 | -0.279 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 51.1 | -2.28 | 13.7 | -4.87 | 10.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10.7 | -10.4 | 2.21 | 0.986 | 17.6 |